Oncology & Cancer

Urine-based test improves on PSA for detecting prostate cancer

A new urine-based test improved prostate cancer detection - including detecting more aggressive forms of prostate cancer - compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.

Oncology & Cancer

New screening method for prostate cancer recurrence

The American Cancer Society estimated that 220,800 new cases of prostate cancer will be diagnosed in the United States in 2015. Approximately 27,540 men will die of the disease, accounting for 5 percent of all cancer deaths.

Oncology & Cancer

MRI—prostate cancer screening for the future?

A screening method that combines a traditional PSA test with an MRI detects a significantly greater number of prostate cancer cases and improves diagnostic accuracy. The study was conducted as part of the largest international ...

Oncology & Cancer

ASCO endorses ACS guideline for prostate CA survivor care

(HealthDay)—The American Society of Clinical Oncology (ASCO) has endorsed the American Cancer Society (ACS) Prostate Cancer Survivorship Care Guidelines, according to a report published online Feb. 9 in the Journal of Clinical ...

Arthritis & Rheumatism

Team finds gene that confirms existence of psoriatic arthritis

PsA is a common form of inflammatory form of arthritis causing pain and stiffness in joints and tendons that can lead to joint damage. Nearly all patients with PsA also have skin psoriasis and, in many cases, the skin disease ...

Oncology & Cancer

Researchers develop optimised PSA screening program

As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers from the Comprehensive Cancer Center at the MedUni Vienna and Vienna ...

page 16 from 33